Return to QS65 Overview

Hepatitis B [QS65]

Measuring the use of this guidance

Statement: 3

Pregnant women who are identified as hepatitis B surface antigen (HBsAg)-positive at antenatal screening are assessed by a specialist within 6 weeks of receiving the screening test result.

Quality standard measure: Proportion of pregnant women who are identified as being HBsAg-positive at antenatal screening who are assessed by a specialist within 6 weeks of receiving the screening test result.
What was measured: The proportion of pregnant women who are hepatitis B positive attending for specialist assessment within 6 weeks of the screen positive result being reported to maternity services.
Data collection end: March 2014
68.1%
Number that met the criteria: 2032 / 2986
Data collection end: March 2015
68.4%
Number that met the criteria: 2123 / 3103
Data collection end: March 2016
73.4%
Number that met the criteria: 2137 / 2911
Area covered: England
Source: Public Health England: National Screening Programme Key Performance Indicators.

Quality standard measure: Proportion of pregnant women who are identified as being HBsAg-positive at antenatal screening who are assessed by a specialist within 6 weeks of receiving the screening test result.
What was measured: Proportion of pregnant women who are hepatitis B positive (newly diagnosed or known positive with high infectivity markers) attending for specialist assessment within 6 weeks of the screen positive result being reported to maternity services.
Data collection end: March 2017
80.3%
Number that met the criteria: 1186 / 1477
Data collection end: March 2018
83.9%
Number that met the criteria: 945 / 1126
Area covered: England
Source: Public Health England: National Screening Programme Key Performance Indicators.



 Return to QS65 Overview